Investors Press Releases Cardiol Therapeutics Closes $1,500,000 Non-Brokered Private Placement March 24, 2017 Cardiol Therapeutics Appoints Afsaneh Lavasanifar, PharmD, PhD to Scientific Advisory Board March 14, 2017 Cardiol Therapeutics Granted Exclusive Global License to Nanotechnology for Heart Failure, Cardiovascular, and Cardiopulmonary Disease January 20, 2017 Page 4 of 4«1234
